Cannell & Spears’s Ventyx Biosciences VTYX Stock Holding History

Cannell & Spears’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-31,000	Closed	-$280K	–	441
2025 Q4	$280K	Buy	31,000 +2,000	+7%	+$14.9K	0.01%	354
2025 Q3	$90.2K	Hold	29,000	–	–	﹤0.01%	396
2025 Q2	$62.1K	Buy	+29,000	New	+$46.8K	﹤0.01%	388

Other funds holding VTYX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Cannell & Spears's VTYX Position: Q1 2026 in Review

Cannell & Spears sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 31,000 shares — an estimated $280K sold.

Cannell & Spears first reported a position in VTYX in Q2 2025 and held it in 3 quarters. The position peaked at $280K in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

Cannell & Spears reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
Cannell & Spears sold 31,000 Ventyx Biosciences shares in Q1 2026, an estimated $280K.
Cannell & Spears first reported a position in Ventyx Biosciences in Q2 2025 and held it in 3 quarters.
Cannell & Spears's Ventyx Biosciences position peaked at $280K in Q4 2025.
1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.